Published on in Vol 8, No 2 (2016):

Why do we need pharmacists in pharmacovigilance systems?

Why do we need pharmacists in pharmacovigilance systems?

Why do we need pharmacists in pharmacovigilance systems?

Authors of this article:

Hale Z Toklu1 ;   Edward Mensah2
The full text of this article is available as a PDF download by clicking here.

Journals

  1. Shin H, Cha J, Lee C, Song H, Jeong H, Kim J, Lee S. The 2011–2020 Trends of Data-Driven Approaches in Medical Informatics for Active Pharmacovigilance. Applied Sciences 2021;11(5):2249 View
  2. Adigwe O, Onavbavba G, Wilson D. Challenges Associated with Addressing Counterfeit Medicines in Nigeria: An Exploration of Pharmacists’ Knowledge, Practices, and Perceptions. Integrated Pharmacy Research and Practice 2022;Volume 11:177 View
  3. Zawiah M, Mukred R, Al-Jamei S, Kadi T, Al-Baidani A, Abu Farha R. Pharmacists' knowledge and perceptions about pharmacovigilance and barriers towards adverse drug reactions reporting in Yemen. Journal of Pharmaceutical Health Services Research 2019;10(1):67 View
  4. De Meestere D, Saevels J. Belgian community pharmacists’ pharmacovigilance perspective and practice. Research in Social and Administrative Pharmacy 2019;15(12):1446 View
  5. Hussain R, Hassali M, ur Rehman A, Muneswarao J, Hashmi F. Physicians’ Understanding and Practices of Pharmacovigilance: Qualitative Experience from a Lower Middle-Income Country. International Journal of Environmental Research and Public Health 2020;17(7):2209 View
  6. da Cruz J, de Carvalho C, da Cruz Silva P, Guerreiro L, Bento T, Costa L, Simões R, Marques R, Castro Fernandes A, Galaio L, Correia A, Leite Resende E, Gonçalves J. Spontaneous Adverse Event Reporting by COVID-19 Vaccinated Healthcare Professionals Through an Electronic Form Implemented by the Hospital Pharmacy. Hospital Pharmacy 2022;57(6):744 View
  7. Madatli F, Abbasalieva T, Hajiev Z. LEVEL OF AWARENESS ABOUT COUNTERFEİT DRUGS. Bulletin of Problems Biology and Medicine 2023;1(2):228 View
  8. Luthra V, Toklu H. Nutrivigilance: the road less traveled. Frontiers in Pharmacology 2023;14 View
  9. Tillman E, Suppes S, Feldman K, Goldman J. Enhancing Pediatric Adverse Drug Reaction Documentation in the Electronic Medical Record. The Journal of Clinical Pharmacology 2021;61(2):181 View
  10. Minaiyan M, Mashhadi Akbar Boojar M, Aghaabdollahian S, Bagheri M. Evaluation of Needs Assessment in Continuing Medical Education Programs for Community Pharmacists in Isfahan, Iran. Journal of Medical Education 2020;19(2) View
  11. Mohiuddin A. Pharmacovigilance: Present Scenario and Future Goals. International Journal of Research Foundation of Hospital and Healthcare Administration 2018;6(2):91 View
  12. Al-Kubaisi K, Elnour A, Sadeq A. Factors influencing pharmacists' participation in continuing education activities in the United Arab Emirates: insights and implications from a cross-sectional study. Journal of Pharmaceutical Policy and Practice 2023;16(1) View
  13. Dokumacı A, Karataş Y. Kahramanmaraş'ta Hastane ve Serbest Eczanelerde Görev Yapan Eczacıların Farmakovijilans Konusundaki Bilgi ve Tutumlarının Araştırılması. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi 2024;19(2):49 View
  14. Lozano-Blázquez A, Makridaki D, Plesan C, Kohl S. Advanced therapy medicinal products. European Journal of Hospital Pharmacy 2024;31(1):63 View
  15. Mallhi T, Liaqat A, Abid A, Khan Y, Alotaibi N, Alzarea A, Tanveer N, Khan T. Multilevel Engagements of Pharmacists During the COVID-19 Pandemic: The Way Forward. Frontiers in Public Health 2020;8 View
  16. Chaumais M, O’Connell C, Savale L, Guignabert C, Perros F, Jaïs X, Sitbon O, Humbert M, Montani D. Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension. International Journal of Clinical Pharmacy 2018;40(4):790 View
  17. Egboh S, Abere S. Gastroparesis: A Multidisciplinary Approach to Management. Cureus 2022 View
  18. Ramadhani C. Chatbots in Pharmacy: A Boon or a Bane for Patient Care and Pharmacy Practice?. Sciences of Pharmacy 2023;2(3):1 View

Books/Policy Documents

  1. Hussain R. Pharmacy Practice Research Case Studies. View
  2. Fossouo J, Mcdonald R, Wickramasinghe N. Digital Disruption in Health Care. View
  3. Ranjan G, Gupta R, Banerjee S. Evidence Based Validation of Traditional Medicines. View